July 27, 2020 / 10:16 PM / in 14 days

Pfizer-BioNTech begin global study of lead COVID-19 vaccine candidate

July 27 (Reuters) - German biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a global study to evaluate their lead COVID-19 vaccine candidate.

The mid-stage study is expected to include about 120 sites globally. (Reporting by Vishwadha Chander in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below